Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials
scientific article
Author/s
author: Christine Katlama, Keikawus Arastéh, Hans-Jürgen Stellbrink, Jean-François Delfraissy, Adriano Lazzarin, Bonaventura Clotet Sala, Julio Montaner, Joseph J Eron, Sharon Walmsley, Daniel Kuritzkes, Peter J Piliero, Lynn Smiley, Calvin Cohen, Jacob P Lalezari, Lucille Donatacci, Joep Lange, Neil E Buss
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.